Clinical factors of drug resistance in juvenile myoclonic epilepsy.
about
The prognosis of idiopathic generalized epilepsyFocal structural changes and cognitive dysfunction in juvenile myoclonic epilepsy.Differences in paracingulate connectivity associated with epileptiform discharges and uncontrolled seizures in genetic generalized epilepsy.Cortical and subcortical contributions to absence seizure onset examined with EEG/fMRISeizure control in patients with idiopathic generalized epilepsies: EEG determinants of medication response.Juvenile myoclonic epilepsy: under-appreciated and under-diagnosedIdiopathic generalized epilepsies: clinical and electroencephalogram diagnosis and treatment.Refractory calculation-induced idiopathic generalized epilepsy: a case report and review of the literature.Clinical Prediction Rule of Drug Resistant Epilepsy in Children.The treatment of juvenile myoclonic epilepsy.Idiopathic generalized epilepsy: Phenotypic and electroencephalographic observations in a large cohort from South IndiaTreatment of myoclonic seizures in patients with juvenile myoclonic epilepsyThe relationship between the localization of the generalized spike and wave discharge generators and the response to valproatePredictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up.Clinical predictors of the long-term social outcome and quality of life in juvenile myoclonic epilepsy: 20-65 years of follow-up.Modern management of juvenile myoclonic epilepsy.Resistance to valproic acid as predictor of treatment resistance in genetic generalized epilepsies.A Systematic Review of Psychiatric and Psychosocial Comorbidities of Genetic Generalised Epilepsies (GGE).High-dose versus low-dose valproate for the treatment of juvenile myoclonic epilepsy: Going from low to high.Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy.Juvenile myoclonic epilepsy: more trials are needed to guide therapy.Phenotypic analysis of juvenile myoclonic epilepsy in Indian families.Juvenile myoclonic epilepsy.Association of refractory complex partial seizures with a polymorphism of ApoE genotype.Outcomes of newly diagnosed idiopathic generalized epilepsy syndromes in a non-pediatric setting.Sleep convulsive seizures predict lack of remission in genetic generalized epilepsies: A retrospective study from a single epilepsy center in Egypt.Brain morphology in juvenile myoclonic epilepsy and absence seizures.Decision making in juvenile myoclonic epilepsy.Risky Decision Making in Juvenile Myoclonic Epilepsy.Epilepsias generalizadas idiopáticas diagnosticadas incorretamente como epilepsias parciais
P2860
Q27024832-D66DCDAD-00FD-44FF-B447-E9A3EC0016DBQ30498019-2DAA8E55-1CE3-4E3B-AA65-A6F3EA7088F5Q33711556-F1D4BDB4-EA5B-4911-8907-A983F98DE569Q34069318-9FF4208A-C335-476E-A36B-EE791BA5423EQ34071733-69479ECB-A394-431C-8243-0B232597F842Q35075606-EA3F33E1-F3C5-4897-AF24-BD2921066B50Q36307856-BAE8F12A-8F64-4042-A671-F67B68B720A7Q36344251-BC345F38-319F-4117-AACD-CFAF8E5D6901Q36496053-372AED49-2530-44AF-B336-0CE786D11335Q36511305-255BF557-420B-4E52-8B1F-8A5C51AE9C9CQ37046663-BA8980ED-1EA0-43EA-94BC-3DAFFB9FBDBAQ37129788-42734329-B032-48CA-BFF1-8B6B8241F940Q37576226-CF6B3545-1B88-477D-95CE-2C67B833C670Q38017730-801ABCF3-87F6-4425-916E-7E4208F194EDQ38177883-A201EDD0-D291-4CDF-9AC6-3F1CE187E06DQ38809047-A8041440-B93C-4C9D-A2C7-74620F4D4B5AQ38946568-C89BB9E8-A1D5-4B26-9778-2502162D14DAQ38977472-48F66C95-4ED8-4F3F-BAC2-32509422642BQ42355550-91D67B64-9101-46FD-8042-1EBA11D4D53BQ42645154-A813A300-6B95-4FA7-9E0F-80BFFE100899Q43146748-065204F6-77C7-4446-B6D7-440714BAA384Q44416338-924700FB-6757-4616-95D9-B41E168C645EQ46698005-6DF6C408-9BB7-43B8-80FD-BC16BC0E3D37Q46733684-D5BC5206-2977-42E1-B299-CCAEBFB8008BQ47580965-C0A2E285-EB4F-4195-9BE2-8FEB2BDA55A7Q47727537-9E65D173-E4FA-4DE8-94AA-F4049FFD466CQ48189934-75D2F655-9D05-4F8A-A99F-17256B196B83Q48318264-5A86BCA9-718D-4744-9C2C-E168A573FA7DQ55352736-73CF3969-8B41-454B-B650-E5DAAB0F399DQ57086628-6374AAA4-A4B0-44EC-AA9E-1807BC148A01
P2860
Clinical factors of drug resistance in juvenile myoclonic epilepsy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical factors of drug resistance in juvenile myoclonic epilepsy.
@ast
Clinical factors of drug resistance in juvenile myoclonic epilepsy.
@en
type
label
Clinical factors of drug resistance in juvenile myoclonic epilepsy.
@ast
Clinical factors of drug resistance in juvenile myoclonic epilepsy.
@en
prefLabel
Clinical factors of drug resistance in juvenile myoclonic epilepsy.
@ast
Clinical factors of drug resistance in juvenile myoclonic epilepsy.
@en
P2093
P356
P1476
Clinical factors of drug resistance in juvenile myoclonic epilepsy.
@en
P2093
P304
P356
10.1136/JNNP.70.2.240
P407
P577
2001-02-01T00:00:00Z